Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#3 in Gentofte
#551 in Denmark
Defensin Therapeutics Aps
Forward Citations = 11
7 inventors:
Defensin Therapeutics Aps
% Expired Patents = 50.0
EPO Patents = 7
Forward Citations = 11
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Birgitte Andersen (4 out of 9 patents)
Karoline Sidelmann Brinch (4 out of 7 patents)
Soeren Kjaerulff (2 out of 7 patents)
4. Tanja Maria Rosenkilde Kjær (2 out of 2 patents)
5. Tanja Maria Rosenkilde Kjaer (2 out of 5 patents)
6. Thomas Kruse (2 out of 5 patents)
7. Per Holse Mygind (2 out of 15 patents)
8. Peter Nordkild (3 patents)
9. Søren Kjærulff (2 patents)
10. Jan Wehkamp (1 patent)
11. Tanja Maria Rosenkilde KJÆR (0 patent)
4 patents:
Company Overview
Defensin Therapeutics Aps is a biotechnology company focused on developing novel therapies based on defensin peptides. These peptides have shown promising potential in combating a wide range of infectious diseases and inflammatory conditions. With a strong focus on research and development, Defensin Therapeutics is committed to advancing these innovative therapies to address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Defensin Therapeutics Aps. Retrieved from https://idiyas.com/company/defensin-therapeutics-aps
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
7 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]